Federal Trade Commission officials at deadline declined to comment on news reports that it had settled a case with pharmaceutical giant Eli Lilly and Co. over privacy violations.
According to news reports, Lilly agreed to pay the FTC an undisclosed fine for releasing a list last summer of patients who used its anti-depressant drug Prozac.
The fine will wrap up an FTC probe that Lilly engaged in unfair or deceptive trade practices when it “mistakenly” revealed the e-mail addresses of more than 700 Prozac users. Those customers had allegedly signed up for Indianapolis-based Lilly’s “Medi-messenger” service. That service sent daily e-mail reminders to customers to take their medicine but let customers to see the e-mail addresses of all recipients of the e-mail.
Network
